These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1412837)

  • 1. Hyperuricemia and gout in renal allograft recipients.
    Delaney V; Sumrani N; Daskalakis P; Hong JH; Sommer BG
    Transplant Proc; 1992 Oct; 24(5):1773-4. PubMed ID: 1412837
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine-induced hyperuricemia and gout.
    Lin HY; Rocher LL; McQuillan MA; Schmaltz S; Palella TD; Fox IH
    N Engl J Med; 1989 Aug; 321(5):287-92. PubMed ID: 2664517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia after renal transplantation.
    Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
    Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-induced hyperuricemia and gout.
    N Engl J Med; 1990 Feb; 322(5):334-6. PubMed ID: 2296276
    [No Abstract]   [Full Text] [Related]  

  • 6. Tophaceous gout in patients with renal transplants treated with cyclosporine A.
    Baethge BA; Work J; Landreneau MD; McDonald JC
    J Rheumatol; 1993 Apr; 20(4):718-20. PubMed ID: 8496871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of malignant tumors in renal transplant recipients receiving cyclosporine.
    Vilardell J; Oppenheimer F; Talbot-Wright R; Ricart MJ; Andreu J; Alcaraz A; Carretero P
    Transplant Proc; 1992 Oct; 24(5):1948. PubMed ID: 1412922
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine-induced hyperuricemia after renal transplant: clinical characteristics and mechanisms.
    Ahn KJ; Kim YS; Lee HC; Park K; Huh KB
    Transplant Proc; 1992 Aug; 24(4):1391-2. PubMed ID: 1496597
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of gout in renal transplant recipients.
    West C; Carpenter BJ; Hakala TR
    Am J Kidney Dis; 1987 Nov; 10(5):369-72. PubMed ID: 3314490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
    Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929
    [No Abstract]   [Full Text] [Related]  

  • 11. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
    Roth D; Miller J
    Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine.
    Burack DA; Griffith BP; Thompson ME; Kahl LE
    Am J Med; 1992 Feb; 92(2):141-6. PubMed ID: 1543197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
    Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature.
    Pilmore HL; Faire B; Dittmer I
    Transplantation; 2001 Nov; 72(10):1703-5. PubMed ID: 11726837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cold ischemia and donor age on renal allograft outcome in the cyclosporine era.
    Cacciarelli TV; Sumrani N; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1992 Oct; 24(5):2044-5. PubMed ID: 1412966
    [No Abstract]   [Full Text] [Related]  

  • 16. Tubular effects of cyclosporine in pediatric renal transplant recipients.
    Laine J; Holmberg C
    Transplant Proc; 1996 Aug; 28(4):2104-6. PubMed ID: 8769167
    [No Abstract]   [Full Text] [Related]  

  • 17. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gout after transplantation.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Duruelo J
    Br J Rheumatol; 1998 May; 37(5):580. PubMed ID: 9651090
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
    Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin induced hyperuricemia and gout.
    Deray G; Assogba U; Le Hoang P; Brillet G; Baumelou B; Ben Hmida M; Jacobs C
    Clin Nephrol; 1990 Mar; 33(3):154. PubMed ID: 2323116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.